Evidence map›Paper›PMID 42293300›Full record

ReviewScience in One Health2026

Microfluidic point-of-care testing for antimicrobial resistance: advances, strategies, and One Health perspectives.

Chenxi Wang, Jun Feng, Chenjia Zhou, Leshan Xiu, Qinqin Hu, Hui Li, Xiaokui Guo, Xu Wang, Min Chen, Kun Yin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Science in One Health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chenxi WangSchool of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Jun FengShanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.
Chenjia ZhouSchool of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Leshan XiuSchool of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Qinqin HuSchool of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Hui LiSchool of Electrical, Computer and Biomedical Engineering, Southern Illinois University Carbondale, Carbondale, IL 62901, USA.
Xiaokui GuoSchool of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Xu WangDepartment of Pathology, College of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Min ChenSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Kun YinSchool of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) stands as a pressing global public health concern, particularly under One Health concept, requiring innovative approaches for effective treatment and control. In this context, point-of-care testing (POCT) emerges as a critical strategy to combat this challenge. Microfluidic systems have the potential to improve AMR management by enabling rapid, accurate, and cost-effective diagnostic strategies toward POCT for early detection and treatment guidance. This review first summarizes the current status of sample processing, manufacturing techniques, design and detection strategies in microfluidic systems. It then highlights the recent advances in microfluidic diagnostics for AMR, including microfluidic platforms for antibiotic resistance genes (ARGs) detection, and antimicrobial susceptibility testing (AST). Finally, the challenges and perspectives for the further development of microfluidic technology in POCT for AMR are discussed under the One Health concept.

Indexed as

Antibiotic resistance geneAntimicrobial resistanceAntimicrobial susceptibility testingMicrofluidic systemPoint-of-care testing

Identifiers

PMID42293300
PMCPMC13255086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.